HLA-DPB1

protein-coding

major histocompatibility complex, class II, DP beta 1, the group of Histocompatibility complex|C1-set domain containing

Gene summary

HLA-DPB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DP molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. [provided by RefSeq, Jul 2008]

Previous symbols:
  • HLA-DP1B

MANE transcript

NM_002121.6

Inheritance

—

ClinVar variants

U:17B:8

Top phenotype

Beryllium disease, chronic, susceptibility to

gnomAD constraint

pLI —, LoF o/e 1.03

Max pathogenic AF

—

Genomic locus

chr6:33,075,936-33,089,696

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~13.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to HLA-DPB1 variants in ClinVar

2 Conditions Cataloged
not providedTotal: 9
Beryllium disease, chronic, susceptibility toTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002121.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
5
clinvar
2
clinvar
12
missense
7
clinvar
1
clinvar
8
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
4
clinvar
4
Total00175325
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 29 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002121.6RefSeqNP_002112.35MANE Select
ENST00000418931.7EnsemblENSP00000408146.25MANE Select
ENST00000416804.2EnsemblENSP00000399832.25Standard
ENST00000416804.3EnsemblENSP00000399832.25Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Antigen processing and presentation - Homo sapiens (human)
  • Cell adhesion molecules (CAMs) - Homo sapiens (human)
  • Type I diabetes mellitus - Homo sapiens (human)
  • Allograft rejection - Homo sapiens (human)
  • Graft-versus-host disease - Homo sapiens (human)

Biological Process

  • antigen processing and presentation of exogenous peptide antigen via MHC class II
  • positive regulation of interferon-gamma production
  • positive regulation of T cell proliferation
  • T cell receptor signaling pathway
  • positive regulation of T cell activation

Molecular Function

  • peptide antigen binding

Cellular Component

  • Golgi membrane
  • lysosomal membrane
  • plasma membrane
  • cell surface
  • endosome membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000418931
Coding exons
5
Length
11276
Individuals with no LoFs
80755
Homozygous LoFs
5273
Heterozygous LoFs
39720
Defined
125748
p
0.199
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.40981460.6730.000007381622
Missense (PolyPhen)3149.5910.62511576
Synonymous1.394861.90.7760.00000316518
Loss of Function-0.1151413.51.037.67e-7130

Population LoF Frequency

PopulationCAFp-valueStatus
African0.320.23notable
Latino/Admixed American0.190.16notable
Ashkenazi Jewish0.220.17notable
East Asian0.250.20notable
Finnish0.170.16notable
European (Non-Finnish)0.230.19notable
South Asian0.340.28notable
Other0.260.21notable

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.;

Recessive Scores

pRec
0.188

Intolerance Scores

LoFtool
0.974
RVIS EVS
3.4
RVIS percentile EVS
99.45

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.226

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.